MGN Pharma Private Limited
About MGN Pharma Private Limited
Data last updated:
MGN Pharma Private Limited is a private limited company based in Delhi, India. It operates in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 19 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2021PTC382487.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Preeti Rani and Alok Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.12 Kh No. 265 G/F Jhangola No. 2 (Blk – C Gali No. – 21) Govind Colony, Delhi, India – 110036.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.22 Lakh, a growth of 50% compared to the previous year. For the same year it recorded a net loss of ₹7.47 Lakh (net margin -337.2%) and EBITDA of -₹10.09 Lakh (EBITDA margin -455.7%). Revenue has grown at a compounded annual rate (CAGR) of 429% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No.12 Kh No. 265 G/F Jhangola No. 2 (Blk – C Gali No. – 21) Govind Colony, Delhi, India – 110036
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of MGN Pharma Private Limited
The main business activity of MGN Pharma is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of MGN Pharma Private Limited FY 2025 filings available
MGN Pharma Private Limited reported revenue of ₹2.22 Lakh (up 50% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of MGN Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 429% over three years, including 50% growth in the latest year. EBITDA fell 582% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of MGN Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | -₹10.09 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹7.47 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of MGN Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -455.7% | •••• | •••• | •••• |
| Net Profit Margin | -337.2% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of MGN Pharma are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of MGN Pharma Private Limited
MGN Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Manufacture of chemicals and chemical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Provena Life Sciences Private Limited | ₹2.33 Lakh (FY 2025) | •••• | •••• | -35.0% | •••• | Kolkata, West Bengal, India |
| Vukkadala Chemicals Private Limited | ₹2.26 Lakh (FY 2025) | •••• | •••• | 10.0% | •••• | Mumbai, Maharashtra, India |
| Sushenah Skin and Health Care Private Limited | ₹2.26 Lakh (FY 2025) | •••• | •••• | 3.0% | •••• | Bangalore, Karnataka, India |
| Vimson Paints and Chemicals Private Limited | ₹2.25 Lakh (FY 2025) | •••• | •••• | -16.0% | •••• | Thane, Maharashtra, India |
| S R M (India) Limited | ₹2.22 Lakh (FY 2024) | •••• | •••• | -99.0% | •••• | New Delhi, Delhi, India |
| MGN Pharma Private Limited this company | ₹2.22 Lakh (FY 2025) | •••• | •••• | 50.0% | •••• | Delhi, India |
| Ocelot Pharma Private Limited | ₹2.17 Lakh (FY 2025) | •••• | •••• | 9.0% | •••• | Bangalore, Karnataka, India |
| Transene Electronic Chemicals India Private Limited | ₹2.16 Lakh (FY 2025) | •••• | •••• | 21543.0% | •••• | Bangalore, Karnataka, India |
| Cyanotec Bio-Products Private Limited | ₹2.1 Lakh (FY 2025) | •••• | •••• | 24.0% | •••• | Bangalore, Karnataka, India |
| Vision Sights Private Limited | ₹1.93 Lakh (FY 2025) | •••• | •••• | •••• | Chennai, Tamil Nadu, India | |
| Chemzn Private Limited | ₹1.84 Lakh (FY 2025) | •••• | •••• | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below MGN Pharma by revenue in the same principal business activity (Manufacture of chemicals and chemical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of MGN Pharma Private Limited
MGN Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Preeti Rani | Director | 19 Jun 2021 | 5 Years 3 Months | Current |
| Alok Kumar | Director | 19 Jun 2021 | 5 Years 3 Months | Current |
Charges & Borrowings of MGN Pharma Private Limited
MGN Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at MGN Pharma Private Limited
Employment history and EPFO contributions of people linked to MGN Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on MGN Pharma Private Limited
MGN Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Alok Kumar was appointed as Director on 19 Jun 2021.
Credit Ratings, Litigation & Regulatory Alerts for MGN Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by MGN Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of MGN Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of MGN Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of MGN Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MGN Pharma Private Limited
MGN Pharma is an active private limited company based in Delhi, India. The company works in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 19 June 2021 (5+ years old) and is registered under CIN U24299DL2021PTC382487.
MGN Pharma reported revenue of ₹2.22 Lakh for FY 2025 (up 50% YoY).
MGN Pharma has 2 current directors:
- Preeti Rani - Director
- Alok Kumar - Director
MGN Pharma reported a net loss of ₹7.47 Lakh (net margin -337.2%) and EBITDA of -₹10.09 Lakh (EBITDA margin -455.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of MGN Pharma is 429% over three years. In the latest year (FY 2025) revenue rose 50%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of MGN Pharma is U24299DL2021PTC382487. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
MGN Pharma was incorporated on 19 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of MGN Pharma by revenue are Provena Life Sciences Private Limited, Vukkadala Chemicals Private Limited, Sushenah Skin and Health Care Private Limited, Vimson Paints and Chemicals Private Limited, S R M (India) Limited and 5 more, all in the same principal business activity (Manufacture of chemicals and chemical products).
Alok Kumar was appointed as Director on 19 Jun 2021. Preeti Rani was appointed as Director on 19 Jun 2021.
The registered office of MGN Pharma is at Plot No.12 Kh No. 265 GF Jhangola No. 2 Blk – C Gali No. – 21 Govind Colony, Delhi, India – 110036.
MGN Pharma has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh.